2016-03-03T00:00:00.000-05:00
Goldman Sachs,-0.54409
Exchange Commission,0.28114
Celgene Co.,0.00476003
integrated biopharmaceutical company,0.302063
strong buy rating,0.276336
price target,-0.0877421
quarterly earnings results,-0.262873
investment portfolio,0.339168
stake,0.401117
midday trading,-0.455421
stock,0.10584
Edge Wealth Management,0.45926
Investment Management Company,0.508259
Hutchens Investment Management,0.339168
InvestorPlace Broker Center,0.555736
Renaissance Investment Group,0.209371
average price target,-0.330299
biopharmaceutical company,0.383856
sell rating,0.40601
personal trading style,0.598412
research note,-0.194638
Celgene,-0.16503
average price,-0.292799
consensus estimate,-0.547592
shares,-0.163262
Capital Investment Services,0.350446
concise daily summary,0.449296
Indiana Trust,0.508259
stock broker,0.245696
consensus rating,0.47757
recent Form,0.28114
quarter,0.407119
new stake,0.350446
